| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Tepha Flexes Marketing Muscle
Posted on 04/09/2007 18:54:20 | Link | Post Comment
by Sara Calabro
Med Tech Sentinel
FDA today gave the thumbs up to Cambridge, MA-based Tepha, to market its TephaFLEX Absorbable Suture product in the U.S. TephaFLEX is the first device that the privately held firm developed from a new class of biopolymers derived from a recombinant DNA technology licensed from the Massachusetts Institute of Technology.
Through a number of corporate partnerships already established by Tepha – including ones with Aesculap AG, HemCon Medical Technologies, LifeCell Corporation (LIFC), NMT Medical (NMTI) and Tornier — this technology is being applied to a wide array of products such as sutures, surgical meshes for orthopedic and hernia repair, anti-adhesion films, hemostats, intra-cardiac devices, absorbable stents, ligament and tendon repair and replacement devices, embolization agents, and drug delivery systems.
The TephaFLEX Absorbable Suture boasts up to 50% greater tensile strength than currently marketed monofilament absorbable sutures. In addition to high strength, the product offers surgeons improved flexibility, good knot security, and prolonged strength retention when implanted.
Source: OneMedPlace.com
____________________
Med Tech Sentinel
FDA today gave the thumbs up to Cambridge, MA-based Tepha, to market its TephaFLEX Absorbable Suture product in the U.S. TephaFLEX is the first device that the privately held firm developed from a new class of biopolymers derived from a recombinant DNA technology licensed from the Massachusetts Institute of Technology.
Through a number of corporate partnerships already established by Tepha – including ones with Aesculap AG, HemCon Medical Technologies, LifeCell Corporation (LIFC), NMT Medical (NMTI) and Tornier — this technology is being applied to a wide array of products such as sutures, surgical meshes for orthopedic and hernia repair, anti-adhesion films, hemostats, intra-cardiac devices, absorbable stents, ligament and tendon repair and replacement devices, embolization agents, and drug delivery systems.
The TephaFLEX Absorbable Suture boasts up to 50% greater tensile strength than currently marketed monofilament absorbable sutures. In addition to high strength, the product offers surgeons improved flexibility, good knot security, and prolonged strength retention when implanted.
Source: OneMedPlace.com
____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
Examples
Morpheus Trading - Tue Sep 02, 2008 05:21AM
NOTE: Please click on the charts below to enlarge them [read more]
NOTE: Please click on the charts below to enlarge them [read more]
Morpheus Trading - Thu Sep 04, 2008 04:34AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Wed Sep 03, 2008 04:35AM
NOTE: Please click on the charts below to enlarge them [read more]
NOTE: Please click on the charts below to enlarge them [read more]
<< My Home | TheMoneyBlogs Home